More on nktr

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+55.8% Growth)
- Ratings (6.3 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Nektar Therapeutics (NQ:NKTR)
Delayed: 72.80 -0.22 (0.3%)
Prev. Close $73.02  
Open$72.09 
52 Wk High$19.98 
52 Wk Low$10.52 
Day High$72.80 
Day Low$70.51 
P/E N/A  
EPS$-1.45 
Volume66,894 

Friends, Peers and Foes (?): LLY, ABBV, BSX, EOSE, SLNO (more...)

Aug 14, 2026 04:50 PM Form SCHEDULE 13G/A NEKTAR THERAPEUTICS Filed by: Two Seas Capital LP
Aug 14, 2026 04:40 PM Form S-8 NEKTAR THERAPEUTICS
Aug 14, 2026 04:20 PM Form SCHEDULE 13G/A NEKTAR THERAPEUTICS Filed by: BIOTECHNOLOGY VALUE FUND L P
Aug 14, 2026 06:10 AM Form 10-Q NEKTAR THERAPEUTICS For: Jun 30
Aug 13, 2026 04:25 PM Form 8-K NEKTAR THERAPEUTICS For: Aug 13
Aug 13, 2026 04:21 PM Nektar Therapeutics (NKTR) Tops Q2 EPS by 77c
Aug 13, 2026 04:15 PM Nektar Therapeutics Announces Second Quarter 2026 Financial Results
Jul 31, 2026 10:45 AM Form SCHEDULE 13G NEKTAR THERAPEUTICS Filed by: VANGUARD CAPITAL MANAGEMENT LLC
Jul 29, 2026 03:23 PM Form SCHEDULE 13G NEKTAR THERAPEUTICS Filed by: BlackRock, Inc.
Jul 28, 2026 06:00 PM Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets
View All Articles

Entities mentioned with NKTR

View All Entities